醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
SEPN · Septerna, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Septerna, Inc.（SEPN）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $72.6M；高管董事有效買入 —、有效賣出 $63.5M。最近申報 2026-10-19。
買入 Bought—
賣出 Sold$72.6M
有效買入 Effective bought—
有效賣出 Effective sold$63.5M
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-15 | Bhatt Elizabeth President and COO | 賣出 Sell | 4,000 | $37.41 | $150K | SEC |
| 2026-09-01 | Long Daniel D. SVP, Drug Discovery | 賣出 Sell | 3,333 | $37.83 | $126K | SEC |
| 2026-08-12 | RA CAPITAL MANAGEMENT, L.P. 10% Owner, Director | 賣出 Sell · 有效 | 1,493,000 | $42.50 | $63.5M | SEC |
| 2026-08-12 | Third Rock Ventures V, L.P. 10% Owner | 賣出 Sell | 147,200 | $50.27 | $7.4M | SEC |
| 2026-08-11 | Bhatt Elizabeth President and COO | 賣出 Sell | 25,000 | $44.00 | $1.1M | SEC |
| 2026-08-03 | Long Daniel D. SVP, Drug Discovery | 賣出 Sell | 3,334 | $34.47 | $115K | SEC |
| 2026-07-15 | Bhatt Elizabeth President and COO | 賣出 Sell | 4,000 | $33.99 | $136K | SEC |
| 2026-07-01 | Long Daniel D. SVP, Drug Discovery | 賣出 Sell | 3,333 | $34.36 | $115K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-01 | Shaikhly Samira Officer | 12,592 | $493K | 10b5-1 |
| 2026-10-01 | Long Daniel D. Officer | 10,001 | $391K | 10b5-1 |
| 2026-08-12 | RA Capital Healthcare Fund LP affiliate | 746,500 | $36.0M | |
| 2026-08-12 | RA Capital Nexus Fund III, L.P. Affiliate | 746,500 | $36.0M | |
| 2026-08-12 | Third Rock Ventures V, L.P. 10% Stockholder | 147,200 | $7.5M | 10b5-1 |
| 2026-08-11 | Bhatt Elizabeth Officer | 29,000 | $1.1M | 10b5-1 |
| 2026-07-15 | Bhatt Elizabeth Officer | 4,000 | $138K | 10b5-1 |
內部人 Insiders
Bhatt Elizabeth、Long Daniel D.、RA CAPITAL MANAGEMENT, L.P.、Third Rock Ventures V, L.P.